0001209191-17-046092.txt : 20170724
0001209191-17-046092.hdr.sgml : 20170724
20170724171630
ACCESSION NUMBER: 0001209191-17-046092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170720
FILED AS OF DATE: 20170724
DATE AS OF CHANGE: 20170724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lo Steven
CENTRAL INDEX KEY: 0001501959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35703
FILM NUMBER: 17978863
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001401667
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770683487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: (424) 248-6500
MAIL ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP
DATE OF NAME CHANGE: 20070601
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-20
0
0001401667
PUMA BIOTECHNOLOGY, INC.
PBYI
0001501959
Lo Steven
C/O PUMA BIOTECHNOLOGY, INC.
10880 WILSHIRE BLVD., SUITE 2150
LOS ANGELES
CA
90024
0
1
0
0
Chief Commercial Officer
COMMON STOCK
2017-07-20
4
S
0
1990
94.901
D
27220
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.
/s/ Steven Lo
2017-07-24